EXECUTIVE ENGAGEMENTS
POOL
13706
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1643
Interactions with Platform & by Email
PARTICIPANTS
411
Unique # Participated
VALIDATIONS
86
Responses Validated*
COMPANIES
52
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
122
PAGES
198
EDITION
19
PRICE
USD 5450
CODE
MCP-1241
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Regenerative Medicine estimated at US$12.2 Billion in the year 2020, is projected to reach a revised size of US$50.2 Billion by 2027, growing at a CAGR of 22.3% over the analysis period 2020-2027. Cell Therapy, one of the segments analyzed in the report, is projected to record a 23.3% CAGR and reach US$25.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Gene Therapy segment is readjusted to a revised 21.9% CAGR for the next 7-year period.
The Regenerative Medicine market in the U.S. is estimated at US$3.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.7 Billion by the year 2027 trailing a CAGR of 21.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 20.1% and 18.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.6% CAGR.
In the global Tissue Engineering segment, USA, Canada, Japan, China and Europe will drive the 21% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.7 Billion in the year 2020 will reach a projected size of US$6.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.9 Billion by the year 2027.
SELECT PLAYERS
AlloSource; Anika Therapeutics, Inc.; Bioventus LLC; DePuy Synthes Spine, Inc.; Exactech, Inc.; Integra LifeSciences Holdings Corp.; LifeNet Health, Inc.; Medtronic, PLC; NovaBone Products LLC; NuVasive, Inc.; Orthofix International N.V.; Osiris Therapeutics, Inc.; Smith & Nephew plc; Stryker Corporation; Wright Medical Technology, Inc.; Zimmer Biomet Holdings, Inc.
SEGMENTS
» Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, Other Product Types) » Material Type (Biologically Derived, Synthetic, Genetically Engineered, Other Material Types) » Application (Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology, Other Applications)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Regenerative Medicine: A Preface |
| Recent Market Activity |
| An Overview of Regenerative Medicine in Bone and Joint Applications |
| Current and Future Analysis |
| Developed Markets Dominate, Developing to Drive Growth |
| Regenerative Medicine - Past, Present & Future |
| Another Revolution in the Making? |
| Conventional Chemical Medicine Vs Regenerative Medicine |
| Regenerative Medicine - Bypassing the Ethical Concerns |
| Regenerative Medicine Throws Up Several New Therapies |
| Current Global Market for Regenerative Medicine |
| Market Potential |
| Therapeutic Companies and Products in Regenerative Medicine - Current Status |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| AlloSource (US) |
| Anika Therapeutics, Inc. (US) |
| Bioventus LLC (US) |
| DePuy Synthes Companies (US) |
| DePuy Synthes Spine, Inc. (US) |
| Exactech, Inc. (US) |
| Integra LifeSciences Holdings Corp. (US) |
| LifeNet Health, Inc. (US) |
| Medtronic, plc (Ireland) |
| NovaBone Products LLC (US) |
| NuVasive, Inc. (US) |
| Orthofix International N.V. (Netherlands) |
| Osiris Therapeutics, Inc. (US) |
| Smith & Nephew plc (UK) |
| Stryker Corporation (US) |
| Wright Medical Technology, Inc. (US) |
| Zimmer Biomet Holdings, Inc. (US) |
| 3. MARKET TRENDS & DRIVERS |
| A Combination of Factors to Drive Regenerative Medicine Market |
| Burgeoning Global Population Offers Significant Growth Opportunities |
| Aging Global Population: Need for New Effective Treatments |
| Increasing Healthcare Spending in Emerging Markets: Opportunities in Store |
| Government Support and Increased Private Sector Participation |
| Investment and Funding Landscape |
| Major M&A Activity and Strategic Alliances in Regenerative Medicine: 2011-2016 |
| Recent Advancements in the Science of Regenerative Medicine |
| Advanced Ceramics Gaining Preeminence in Regenerative Medicine Field |
| 3D Organ & Tissue Printing: Still in Early Stages |
| Nanotechnology in Regenerative Medicine |
| Issues to be Sorted Out |
| Need for New Scientific and Technological Standards |
| Standardized Guidelines |
| Clinical Translation - Collaboration of Multidisciplinary Skills is Essential |
| The Question of Apt Business Models - The Service and Product Approach |
| Autologous or Service Approach Preferred by European Firms |
| Allogenic or Product Approach - Slow to Develop |
| Regenerative Medicine Requires Improved Biomaterials |
| Investors Wary of Funding Regenerative Medicine |
| Regenerative Medicine Field Lags Behind Due to Segregated Focus |
| Challenges Encountered by Regenerative Medicine |
| Scientific and Technological Challenges |
| Barriers in Sharing Intellectual Property Rights |
| Viable Manufacturing Technologies and Skilled Personnel Crucial |
| Strict Regulations Push up Operational Costs |
| Challenges Facing Autologous Cell Therapies |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Biologically Derived by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biologically Derived by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biologically Derived by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Synthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Genetically Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Genetically Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Genetically Engineered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Material Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Material Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Material Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Musculoskeletal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Regenerative Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Regenerative Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 52 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com